Endothelial cells derived from FPAH patients were defective in cell survival, adhesion, migration, tube formation and BMPR2 signaling, whilst unaffected mutation carriers as well as CRISPR corrected iPSC-ECs were not. This evidence concerns the gene BMPR2 and heritable pulmonary arterial hypertension.